Literature DB >> 16499957

Long-term semi-permanent catheter use for the palliation of malignant ascites.

Rebecca A Brooks1, Thomas J Herzog.   

Abstract

BACKGROUND: Malignant ascites is a common complication of advanced or recurrent ovarian cancer and multiple other neoplasms, causing significant patient morbidity as well as a large treatment obstacle for the physician. While multiple methods of peritoneal drainage have been reported, including large volume therapeutic paracentesis, peritoneogastric, peritoneourinary, and peritoneovenous shunting procedures, peritoneal port-a-catheter placement and hemodialysis catheter drainage, all have their associated limitations and adverse effects. CASE: We report off label semi-permanent catheter placement in a patient for treatment of malignant ascites that functioned effectively with drainage of 2 l daily for approximately 18 months, the longest reported use in the literature.
CONCLUSION: Long-term semi-permanent catheter use is a potentially valuable modality for the palliation of malignant ascites.

Entities:  

Mesh:

Year:  2006        PMID: 16499957     DOI: 10.1016/j.ygyno.2005.12.043

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  7 in total

1.  Percutaneous management of malignant fluid collections.

Authors:  Leann S Stokes
Journal:  Semin Intervent Radiol       Date:  2007-12       Impact factor: 1.513

2.  Surgery in platinum-resistant recurrent epithelial ovarian carcinoma.

Authors:  Ling-Qin Zhao; Wen Gao; Ping Zhang; Ying-Li Zhang; Chen-Yan Fang; Hua-Feng Shou
Journal:  World J Clin Cases       Date:  2022-04-26       Impact factor: 1.534

3.  Palliative treatment of malignant ascites: profile of catumaxomab.

Authors:  Lila Ammouri; Eric E Prommer
Journal:  Biologics       Date:  2010-05-25

Review 4.  Quality-of-life issues in the management of epithelial ovarian cancer.

Authors:  Thomas Lowe; Betty Ferrell; Lucille Leong
Journal:  Curr Treat Options Oncol       Date:  2007-12

5.  Multiline treatment combining apatinib with toptecan for platinum-resistant recurrent ovarian cancer patients: a report of three cases.

Authors:  Yuan Cheng; Juan Zhang; Haiyun Geng; Shukui Qin; Haiqing Hua
Journal:  Onco Targets Ther       Date:  2018-04-06       Impact factor: 4.147

6.  Management of drainage for malignant ascites in gynaecological cancer.

Authors:  Chumnan Kietpeerakool; Siwanon Rattanakanokchai; Nampet Jampathong; Jatupol Srisomboon; Pisake Lumbiganon
Journal:  Cochrane Database Syst Rev       Date:  2019-12-11

7.  Management of malignant pleural effusion and ascites by a triple access multi perforated large diameter catheter port system.

Authors:  Ihsan Inan; Sandra De Sousa; Patrick O Myers; Brigitte Bouclier; Pierre-Yves Dietrich; Monica E Hagen; Philippe Morel
Journal:  World J Surg Oncol       Date:  2008-08-18       Impact factor: 2.754

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.